Herbal Composition for Senile Dementia via Synergistic Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for senile dementia, such as acetylcholinesterase inhibitors and anti-inflammatory drugs, only temporarily alleviate cognitive decline without halting disease progression, and often come with adverse effects and high costs, necessitating a more effective, safer, and affordable therapeutic option.
Innovation Solution
A pharmaceutical composition comprising Epimedium, Poria, and optionally Acanthopanax and Anemarrhenae Rhizoma, extracted using specific solvent ratios and extraction processes, is formulated to treat or prevent senile dementia, with the ingredients being traditional Chinese medicinal materials that address the underlying kidney deficiency and malnutrition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional drugs such as acetylcholinesterase inhibitors and anti-inflammatory drugs are used to treat senile dementia, then cognitive functions are temporarily relieved, but the disease progression cannot be suspended and adverse effects occur
Solution Approach 1:
The patent uses a composite formulation combining multiple traditional Chinese medicine ingredients (Epimedium, Poria, Acanthopanax, Anemarrhenae Rhizoma) to create a synergistic therapeutic effect. This composite approach addresses the limitations of single-drug therapies by combining multiple active components that work together to improve cognitive function while reducing adverse effects through balanced pharmacological actions.
Solution Approach 2:
The patent optimizes the dosage ratios of each ingredient within specific ranges (Epimedium 20-50 parts, Poria 15-55 parts, Acanthopanax 10-55 parts, Anemarrhenae Rhizoma 5-20 parts) to achieve the desired therapeutic effect while minimizing toxicity. This parameter optimization allows the formulation to maintain efficacy while reducing the harmful effects associated with conventional drugs.
2Reliability
If conventional drugs are used for treating senile dementia, then some therapeutic effect is achieved, but the cost is too high for patients and family members
Solution Approach 1:
The patent employs traditional Chinese medicine materials that are more affordable and accessible compared to conventional Western medications. These herbal ingredients can be sourced at lower costs and are suitable for long-term use, making the treatment economically viable for patients and families while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent optimizes the dosage ratios of each ingredient within specific ranges to achieve cost-effective formulations. By carefully controlling the proportions of Epimedium (20-50 parts), Poria (15-55 parts), Acanthopanax (10-55 parts), and Anemarrhenae Rhizoma (5-20 parts), the formulation achieves therapeutic efficacy at a lower cost compared to conventional medications.
3Ease of operation
If conventional drugs are used to treat senile dementia, then cognitive symptoms are temporarily alleviated, but the progression of the disease cannot be halted
Solution Approach 1:
The patent adopts a preventive and curative approach by addressing the root cause of senile dementia through kidney tonification and essence strengthening before significant cognitive deterioration occurs. The formulation not only relieves existing symptoms but also prevents further disease progression by reinforcing the kidney essence and improving overall brain function through the synergistic action of multiple herbal ingredients.
Solution Approach 2:
The multi-ingredient composite formulation provides comprehensive action that both relieves cognitive symptoms and addresses the underlying pathogenesis of senile dementia. The combination of Epimedium (kidney Yang tonification), Poria (dampness removal and spleen strengthening), Acanthopanax (qi invigoration and kidney tonification), and Anemarrhenae Rhizoma (heat clearing and Yin nourishment) creates a balanced therapeutic effect that simultaneously manages symptoms and slows disease progression.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition demonstrates significant improvement in learning and memory functions in animal models and clinical trials, showing potential as a curative and preventive measure for senile dementia with reduced side effects and improved affordability.
Implementation Method 1
extracted using specific solvent ratios and extraction processes
Data Source
AI summary
The present disclosure relates to a pharmaceutical composition for preventing and treating senile dementia and preparation method thereof. The active ingredients of the pharmaceutical composition are prepared from raw medicinal materials comprising 20-50 parts by weight of Epimedii Folium and 15-55 parts by weight of Poria; or from raw medicinal materials comprising 20-50 parts by weight of Epimedii Folium, 15-55 parts by weight of Poria and 10-55 parts by weight of Acanthopanax, or from raw medicinal materials comprising 20-50 parts by weight of Epimedii Folium, 15-50 parts by weight of Poria, 15-50 parts by weight of Acanthopanax and 6-15 parts by weight of Anemarrhenae Rhizoma.